BioAmber looks to clean up with $136m France and US IPO
BioAmber, a Canadian clean-tech chemicals start-up with operations in France, began roadshows on Wednesday for a float that it hopes will raise $136m through a dual listing in New York and Paris.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts